2.55 USD
↘ 0.02 (0.78%)AT CLOSE (03:59 PM EDT)
Protalix BioTherapeutics, Inc. Common Stock (PLX) is currently trading at $2.55. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (26.5%) and a bullish Golden Cross on the moving averages. Valuation metrics suggest PLX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 23, 2026.